Spectrum of lymphoproliferative disorders following renal transplantation in North India.

scientific article published on July 2013

Spectrum of lymphoproliferative disorders following renal transplantation in North India. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4103/0971-4065.114504
P932PMC publication ID3741974
P698PubMed publication ID23960346
P5875ResearchGate publication ID255987264

P50authorAshish SharmaQ57334406
Ritambhra NadaQ71636749
Vivekanand JhaQ38800410
P2093author name stringR Ramachandran
V Sakhuja
M Rathi
K Joshi
K L Gupta
H S Kohli
M Minz
P2860cites workPosttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppressionQ46825318
Cancers complicating organ transplantationQ68613885
Pretransplantation assessment of the risk of lymphoproliferative disorderQ71910946
Twenty and 25 years survival after cadaveric renal transplantationQ72339348
Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipientsQ72659857
Lymphomas occurring late after solid-organ transplantation: influence of treatment on the clinical outcomeQ78534522
Myeloma, Hodgkin disease, and lymphoid leukemia after renal transplantation: characteristics, risk factors and prognosisQ82996536
Lymphoproliferative disorders in renal transplant recipients: a single-centre experienceQ82999899
Lymphoproliferative disorders in Oxford renal transplant recipientsQ35586818
The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: A potential approach to prevention and treatment of posttransplant lymphoproliferative disordersQ35680531
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppressionQ35818660
Lymphoproliferative disease after renal transplantation in Australia and New ZealandQ36205802
Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patientsQ40625214
Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy.Q40834086
Incidence and consequences of post-transplantation lymphoproliferative disordersQ41546087
Epstein-Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplantQ44116989
Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantationQ44662215
Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?Q45755509
Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.Q46006774
Post-transplant lymphoproliferative disorders after live donor renal transplantationQ46690570
P433issue4
P921main subjectIndiaQ668
lymphoproliferative disordersQ4165484
P304page(s)287-291
P577publication date2013-07-01
P1433published inIndian Journal of NephrologyQ6020793
P1476titleSpectrum of lymphoproliferative disorders following renal transplantation in North India
P478volume23

Reverse relations

cites work (P2860)
Q55339839Carcinoma of the Tongue in Renal Transplant Recipients: An Unusual Spectrum of De novo Malignancy at a Tertiary Care Center in India Over a Period of 26 Years.
Q39501295Epstein-Barr virus-positive multiple myeloma following an ABO incompatible second renal transplantation
Q57123042Late Posttransplant Lymphoproliferative Disease: Report of a Rare Case and Role of Positron Emission Tomography-computed Tomography
Q57123093Posttransplant Lymphoproliferative Disorder: Experience from a Pediatric Nephrology Unit in North India

Search more.